Please ensure Javascript is enabled for purposes of website accessibility

NY declares victory in Alzheimer’s drug antitrust lawsuit

By: The Associated Press//November 25, 2015

NY declares victory in Alzheimer’s drug antitrust lawsuit

By: The Associated Press//November 25, 2015//

Listen to this article

ALBANY — New York’s attorney general is dropping a lawsuit against a drug manufacturer after blocking what he said was an attempt to switch Alzheimer’s patients to a newer patented drug.

Attorney General Eric Schneiderman had sued Allergan PLC to prevent the company from withdrawing Namenda, a popular Alzheimer’s treatment, a few months before lower-cost generic drugs became available.

Schniederman’s office argued the move was timed to force patients onto a new patented drug Namenda XR instead of the generics.

A federal judge agreed, requiring Allergan to continue distributing the older drug until generics were available.

Schneiderman said Wednesday the lawsuit has been resolved now that patients can choose between the new drug and generic alternatives.

Allergan, previously known as Actavis, confirmed the settlement. The company agreed to pay $172,000 in legal fees.

Case Digests

See all Case Digests

Law News

See All Law News

Polls

How Is My Site?

View Results

Loading ... Loading ...